Corestreet Logo

Lexicon Pharmaceuticals Inc (LXRX) Insider Trading

Total insider buys:
  • $304,088,182.43
Total insider sells:
  • $551,529.66
Most recent insider trade:
  • Nov. 16, 2023
Most active insider trader:
  • Public Equities L.P. Invus
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 16, 2023CEO90,000$1.05Buy$94,500.00
Nov. 10, 2023CEO10,000$1.01Buy$10,100.00
Oct. 12, 2023Director148,820$1.03Buy$153,284.60
Oct. 10, 2023Director508,306$1.14Buy$579,468.84
Sept. 14, 2023CFO10,000$1.38Buy$13,800.00
Aug. 4, 2023VP6,000$1.84Buy$11,040.00
June 29, 2023CEO10,000$2.16Buy$21,600.00
June 26, 2023CEO10,000$2.18Buy$21,800.00
June 23, 2023VP10,000$2.43Buy$24,300.00
June 22, 2023CEO40,000$2.31Buy$92,400.00
June 20, 2023CFO12,000$2.33Buy$27,960.00
June 5, 2023Director27,775,050$2.60Buy$72,215,130.00
Aug. 1, 2022Director16,173,800$2.50Buy$40,434,500.00
March 15, 2021VP22,912$6.92Sell$158,551.04
Sept. 18, 2019EVP4,500$3.36Buy$15,120.00
Sept. 17, 2019CEO50,000$3.13Buy$156,500.00
Sept. 16, 2019Director25,000$2.55Buy$63,750.00
Sept. 13, 2019Director99,249$2.41Buy$239,190.09
Aug. 19, 2019Insider40,000$1.35Buy$54,000.00
Aug. 16, 2019CEO37,000$1.35Buy$49,950.00
Aug. 2, 2019VP10,000$1.14Buy$11,400.00
Aug. 2, 2019Director24,000$1.18Buy$28,320.00
June 28, 2018Director182,838$12.51Buy$2,287,303.38
June 25, 2018Director253,725$12.99Buy$3,295,887.75
June 21, 2018Director72,973$13.29Buy$969,811.17
June 18, 2018Director45,784$12.98Buy$594,276.32
June 14, 2018Director9,200$12.66Buy$116,472.00
June 11, 2018Director98,626$12.75Buy$1,257,481.50
June 8, 2018Director29,747$12.89Buy$383,438.83
June 8, 2018VP10,000$12.91Sell$129,100.00
June 6, 2018Director95,079$12.58Buy$1,196,093.82
June 4, 2018Director416,481$12.01Buy$5,001,936.81
June 1, 2018Director147,339$12.22Buy$1,800,482.58
May 30, 2018Director433,378$9.94Buy$4,307,777.32
May 25, 2018Director138,700$9.62Buy$1,334,294.00
May 23, 2018EVP745$9.78Buy$7,286.10
Nov. 17, 2017Director180,727$10.11Buy$1,827,149.97
Nov. 15, 2017CEO10,000$9.91Buy$99,100.00
Nov. 14, 2017EVP2,000$9.48Buy$18,960.00
Nov. 14, 2017Director575,946$9.64Buy$5,552,119.44
Nov. 10, 2017Director145,680$9.74Buy$1,418,923.20
Sept. 15, 2017Director1,000$12.50Buy$12,500.00
Sept. 15, 2017Insider30,000$12.54Buy$376,200.00
June 6, 2016VP1,500$15.00Sell$22,500.00
May 23, 2016VP6,000$13.00Sell$78,000.00
Dec. 12, 2014Director150,000$0.88Buy$132,000.00
Dec. 10, 2014Director315,896$0.90Buy$284,306.40
Nov. 26, 2014Director149,253,731$1.01Buy$150,746,268.31
Oct. 25, 2013CFO227,626$0.13Sell$29,591.38
Oct. 9, 2013CFO83,281$0.19Sell$15,823.39
First«1 of 2»Last

  • Insiders are both buying and selling Lexicon Pharmaceuticals Inc stock.

  • The insider traders at Lexicon Pharmaceuticals Inc are: Public Equities L.P. Invus, Lonnel Coats, Alexander Richard Walsh, James F Tessmer, International S.C.A. Artal, Bryan A Kleinlein, Jeffrey L Wade, Wendy Mcdermott, Christopher J Sobecki, C.V. Invus, Raymond Debbane, Sam L Barker, and Alexander A Santini

  • The most active insider trader at Lexicon Pharmaceuticals Inc is Public Equities L.P. Invus with 15 trades.

  • James F Tessmer has sold the most Lexicon Pharmaceuticals Inc stock with a total value of $546,702.08.

  • International S.C.A. Artal has bought the most Lexicon Pharmaceuticals Inc stock with a total value of $342,361,028.31.

  • The most recent insider trade for Lexicon Pharmaceuticals Inc was on Nov. 16, 2023.

  • The single biggest insider buy for Lexicon Pharmaceuticals Inc was from International S.C.A. Artal with a total value of $150,746,268.31 on Nov. 26, 2014.

  • The single biggest insider sell for Lexicon Pharmaceuticals Inc was from James F Tessmer with a total value of $158,551.04 on March 15, 2021.